RBBP9
Basic information
Region (hg38): 20:18486540-18497225
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RBBP9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 17 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 1 | 0 |
Variants in RBBP9
This is a list of pathogenic ClinVar variants found in the RBBP9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-18489793-C-T | not specified | Uncertain significance (Nov 09, 2021) | ||
20-18489806-T-G | not specified | Uncertain significance (Jun 06, 2023) | ||
20-18489810-T-C | not specified | Uncertain significance (Feb 07, 2025) | ||
20-18489875-G-A | Likely benign (Jun 01, 2022) | |||
20-18489907-A-G | not specified | Uncertain significance (Feb 22, 2023) | ||
20-18489960-T-C | not specified | Uncertain significance (Jan 31, 2024) | ||
20-18490400-G-C | not specified | Uncertain significance (Jun 26, 2024) | ||
20-18490403-C-A | not specified | Uncertain significance (Aug 28, 2024) | ||
20-18490403-C-G | not specified | Uncertain significance (Jan 19, 2024) | ||
20-18490436-G-A | not specified | Uncertain significance (May 10, 2023) | ||
20-18493967-G-A | not specified | Uncertain significance (Jul 30, 2024) | ||
20-18493968-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
20-18493980-A-G | not specified | Uncertain significance (Jan 17, 2025) | ||
20-18493991-A-G | not specified | Uncertain significance (Feb 26, 2025) | ||
20-18494015-T-C | not specified | Uncertain significance (Apr 25, 2022) | ||
20-18494036-G-C | not specified | Uncertain significance (May 24, 2023) | ||
20-18494051-T-C | not specified | Uncertain significance (Dec 02, 2024) | ||
20-18494057-G-C | not specified | Uncertain significance (Jun 26, 2024) | ||
20-18497119-C-A | not specified | Uncertain significance (Mar 24, 2023) | ||
20-18497122-C-T | not specified | Uncertain significance (Jul 02, 2024) | ||
20-18497143-T-C | not specified | Uncertain significance (Dec 13, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RBBP9 | protein_coding | protein_coding | ENST00000337227 | 5 | 10704 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0486 | 0.931 | 125715 | 0 | 30 | 125745 | 0.000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.234 | 100 | 107 | 0.936 | 0.00000559 | 1222 |
Missense in Polyphen | 38 | 44.009 | 0.86346 | 500 | ||
Synonymous | 0.973 | 33 | 40.9 | 0.806 | 0.00000232 | 344 |
Loss of Function | 2.01 | 4 | 11.3 | 0.354 | 6.45e-7 | 116 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000214 | 0.000214 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000141 | 0.000141 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000261 | 0.000261 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in the transformation process due to its capacity to confer resistance to the growth-inhibitory effects of TGF-beta1 through interaction with retinoblastoma and the subsequent displacement of E2F-1.;
Recessive Scores
- pRec
- 0.157
Intolerance Scores
- loftool
- 0.389
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 46.49
Haploinsufficiency Scores
- pHI
- 0.275
- hipred
- N
- hipred_score
- 0.369
- ghis
- 0.620
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.973
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rbbp9
- Phenotype
Gene ontology
- Biological process
- regulation of cell population proliferation
- Cellular component
- nucleoplasm;cytoplasm
- Molecular function
- protein binding;hydrolase activity